Dr. Alexander Bondoc · Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study
Follow
Article1 min read·Published May 2022Older

Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · May 2022 · 1 min read

In brief

In brief

Multi-institutional study of 262 pediatric patients with hepatocellular neoplasms reveals distinct prognostic patterns across histologic subtypes. Conventional HCC showed worse outcomes than fibrolamellar carcinoma, with mortality predicted by tumor resectability, multifocality, and PRETEXT stage IV disease.

Written by the GCMD Library team from the article.

Alexander Bondoc

Background: Hepatocellular carcinoma (HCC) is a rare cancer in children, with various histologic subtypes and a paucity of data to guide clinical management and predict prognosis. Methods: A multi-institutional review of children with hepatocellular neoplasms was performed, including demographic, staging, treatment, and outcomes data. Patients were categorized as having conventional HCC (cHCC) with or without underlying liver disease, fibrolamellar carcinoma (FLC), and hepatoblastoma with HCC features (HB-HCC). Univariate and multivariate analyses identified predictors of mortality and relapse. Results: In total, 262 children were identified; and an institutional histologic review revealed 110 cHCCs (42%; 69 normal background liver, 34 inflammatory/cirrhotic, 7 unknown), 119 FLCs (45%), and 33 HB-HCCs (12%). The authors observed notable differences in presentation and behavior among tumor subtypes, including increased lymph node involvement in FLC and higher stage in cHCC. Factors associated with mortality included cHCC (hazard ratio [HR], 1.63; P = .038), elevated α-fetoprotein (HR, 3.1; P = .014), multifocality (HR, 2.4; P < .001), and PRETEXT (pretreatment extent of disease) stage IV (HR, 5.76; P < .001). Multivariate analysis identified increased mortality in cHCC versus FLC (HR, 2.2; P = .004) and in unresectable tumors (HR, 3.4; P < .001). Disease-free status at any point predicted survival. Conclusions: This multi-institutional, detailed data set allowed a comprehensiv

Statements in this article

  1. Pediatric hepatocellular neoplasms were categorized into three histologic subtypes: conventional HCC with or without underlying liver disease, fibrolamellar carcinoma, and hepatoblastoma with HCC features.

    Established
  2. Among 262 children with hepatocellular neoplasms, institutional histologic review identified 110 conventional HCCs (42%), 119 fibrolamellar carcinomas (45%), and 33 hepatoblastomas with HCC features (12%).

    Research
  3. Of 110 conventional HCC cases, 69 occurred in normal background liver, 34 in inflammatory or cirrhotic liver, and 7 had unknown background liver status.

    Research
  4. Fibrolamellar carcinoma showed increased lymph node involvement compared to other hepatocellular neoplasm subtypes.

    Research
  5. Conventional HCC presented at higher stage compared to other hepatocellular neoplasm subtypes.

    Research
  6. Conventional HCC histology was associated with increased mortality (hazard ratio 1.63, P = .038).

    Research
  7. Elevated α-fetoprotein was associated with increased mortality (hazard ratio 3.1, P = .014).

    Research
  8. Multifocal disease was associated with increased mortality (hazard ratio 2.4, P < .001).

    Research
  9. PRETEXT stage IV disease was associated with increased mortality (hazard ratio 5.76, P < .001).

    Research
  10. Multivariate analysis identified conventional HCC versus fibrolamellar carcinoma as an independent predictor of increased mortality (hazard ratio 2.2, P = .004).

    Research
  11. Unresectable tumors were independently associated with increased mortality (hazard ratio 3.4, P < .001).

    Research
  12. Disease-free status at any point during treatment predicted survival in pediatric hepatocellular neoplasms.

    Research

Read it at the source ↗

Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.